BASF to Establish World-Scale Specialty Amines Plant in Nanjing, China
BASF will build a new world scale production plant to manufacture specialty amines at its existing wholly-owned site in the Nanjing Chemical Industry Park in China. The plant, which is scheduled to come on stream in late 2015, will have dimethylaminopropylamine (DMAPA) and polyetheramines (PEA) as the main products. With this new facility BASF will further strengthen its global production network. The new plant complements existing facilities in Germany and the US for DMAPA and PEA.
“BASF is a leading supplier of DMAPA and PEA globally, and this investment reflects our continued commitment to meeting the growing market demand in Asia Pacific,” said Sanjeev Gandhi, President of BASF’s Intermediates division. “Our ability to produce these products within the region will strengthen our supply reliability and better serve our customers with shorter lead times.”
“The investment is driven by the increasing consumption of personal care products by the growing middle class in China and in Asia,” said Dr Guido Voit, Senior Vice President, BASF Intermediates, Asia Pacific. “Additionally, the development in the construction, wind energy and coatings industries in China and other emerging countries in Asia will continue to drive demand for PEA.”
DMAPA is mainly consumed in the production of betaines, which are used as co-surfactants in personal care products like shampoo and body wash. DMAPA is also used in various other applications including dye-stuff intermediates, lubricant additives, electroplating, coupling agents for rubber and others.
PEA is an intermediate chemical for epoxy curing agents used in the production of plastics, polyurea coatings, adhesives, reaction injection moulding and wind blade composites. BASF offers polyetheramines under its Baxxodur brand.
BASF has manufacturing capacities for both products at its sites in Ludwigshafen, Germany, and in Geismar, Louisiana.
For further information, click here.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance